Cart
sales@molnova.com
SDZ-62-434
CAS No. 115621-95-9
SDZ-62-434( —— )
Catalog No. M34417 CAS No. 115621-95-9
SDZ-62-434, a platelet-activating factor inhibitor with antitumor activity, inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells, making it a potential candidate for studying leukemia, human xenograft colorectal cancer, and lung cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 246 | In Stock |
|
| 5MG | 411 | In Stock |
|
| 10MG | 562 | In Stock |
|
| 25MG | 866 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSDZ-62-434
-
NoteResearch use only, not for human use.
-
Brief DescriptionSDZ-62-434, a platelet-activating factor inhibitor with antitumor activity, inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells, making it a potential candidate for studying leukemia, human xenograft colorectal cancer, and lung cancer.
-
DescriptionSDZ-62-434 is a platelet-activating factor (PAF) antagonist. SDZ-62-434 has antiproliferative activity in human solid and haematological malignancies.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetPlatelet aggregation
-
RecptorPlatelet aggregation
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number115621-95-9
-
Formula Weight416.39
-
Molecular FormulaC23H27Cl2N3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC12=NCCN1C(C3=CC=C(CN4CCCCC4)C=C3)=CC5=C2C=CC=C5.Cl.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. V G Brunton, et al. In vitro antitumour activity of the novel imidazoisoquinoline SDZ 62-434. Br J Cancer. 1993 May;67(5):989-95.?
molnova catalog
related products
-
48740 RP
48740 RP is an antagonist of platelet-activating factor.
-
Benzcyclane
Benzcyclane (Benzcyclan) is an inhibitor of platelet aggregation and also a vasodilator that can be used in a variety of peripheral circulation disorders.
-
Mutant EGFR inhibito...
Mutant EGFR inhibitor is a selective and potent Mutated EGFR inhibitor, inhibits L858R activating mutant, the Exonl9 deletion activating mutant and the T790M resistance mutant.
